Otamixaban

Otamixaban
Otamixaban
Systematic (IUPAC) name
Methyl (2R,3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 193153-04-7 YesY
ATC code None
PubChem CID 5496659
ChemSpider 4593439 YesY
UNII S173RED00L N
ChEMBL CHEMBL46618 YesY
Chemical data
Formula C25H26N4O4 
Mol. mass 446.498 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Otamixaban (INN) is a direct factor Xa inhibitor,[1] currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.

References